 Zynerba Pharmaceuticals NASDAQ:ZYNE Inc has announced the appointment of Albert P Parker as the companys new chief legal officer and corporate secretary. Parker, an accomplished industry executive with over 25 years of pharmaceutical, biotech and healthcare experience, will assume the duties of Suzanne Hanlon, who will retire from her position at the end of February 2022, the company said. 